Muckle-wells Syndrome
📧 Sign up to get email alerts when something new happens for Muckle-wells Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase [Phase 3]
Phase 3 study assessing 6-month efficacy and safety of canakinumab in Japanese patients with cryopyrin-associated periodic syndromes, includ…
-
CLINICAL_TRIALS trial_result · 2016-08-03Clinical Trial Update: Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease [Phase 3]
Phase 3 trial assessing efficacy, safety and tolerability of ACZ885 (canakinumab) in pediatric patients with cryopyrin-associated periodic s…
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients
This registry study assesses clinical outcomes and safety of canakinumab (Ilaris) in patients with cryopyrin-associated periodic syndromes (…
-
CLINICAL_TRIALS trial_result · 2015-08-18Clinical Trial Update: Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease [Phase 3]
Phase 3 trial evaluating ACZ885 (canakinumab) for efficacy, safety and tolerability in pediatric patients with Cryopyrin-associated periodic…
-
CLINICAL_TRIALS trial_result · 2012-05-31Clinical Trial Update: Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS) [Phase 2]
Phase 2 clinical trial assessing the safety and tolerability of rilonacept in patients with Muckle-Wells Syndrome and Schnitzler Syndrome; t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-05-27Clinical Trial Update: Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease [Phase 3]
Phase 3 study evaluating ACZ885 (canakinumab) for efficacy and safety in cryopyrin-associated periodic syndromes, including familial cold au…
-
CLINICAL_TRIALS trial_result · 2011-02-11Clinical Trial Update: Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome [Phase 3]
Phase 3 trial update reporting efficacy, safety, and tolerability of ACZ885 (canakinumab) in patients with Muckle-Wells syndrome; results po…
-
CLINICAL_TRIALS trial_result · 2009-11-13Clinical Trial Update: Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) [Phase 3]
Phase 3 trial of rilonacept for Cryopyrin-associated periodic syndromes (CAPS) completed with results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-02-17Clinical Trial Update: Safety, Efficacy, Pharmacokinetics, Pharmacodynamics of ACZ885 in Patients With NALP3 Mutations and Clinical Symptoms [Phase 2]
Phase 2 trial update evaluating safety, efficacy, pharmacokinetics and pharmacodynamics of ACZ885 (canakinumab) in patients with NLRP3 mutat…